ArticleBMC endocrine disorders2025
Ectopic parathyroid adenoma: successful localization with 18F-fluorocholine PET/CT and parathyroid venous sampling in two cases.
Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundClinically suspected parathyroid adenomas, which are not localized by conventional imaging such as ultrasonography and technetium-99 m (99mTc) sestamibi scintigraphy, remain challenging. We describe two patients with hypercalcemia and elevated parathyroid hormone (PTH) levels, in whom ultrasonography or technetium-99 m sestamibi scintigraphy failed to identify the lesions. Both were successfully localized by novel combined use of fluorine 18 (18F) fluorocholine positron emission tomography/computed tomography (FCH PET/CT) in conjunction with parathyroid venous sampling (PVS). CASE PRESENTATION: In the first case of 59 year-old Korean man with diabetes, a 2.0-cm mass in the left mediastinum was identified and removed via thoracoscopic robotic excision, with histopathology confirming an ectopic parathyroid adenoma. Postoperatively, serum calcium, PTH and creatinine levels improved, and the patient’s daily insulin requirement decreased from 90 to 15 units. In the second case of 55 year-old Korean woman, a 0.8-cm nodule was localized in the retropharyngeal space posterior to the right pyriform sinus. Due to the deep location and high surgical risk, the patient was managed non-surgically with annual intravenous bisphosphonate to control hypercalcemia and prevent bone loss.
conclusionsThese cases highlight the diagnostic value of FCH PET/CT and PVS for precise localization of parathyroid adenomas not detectable by first-line imaging, enabling optimal management and potentially improving outcomes beyond calcium and bone metabolism, including renal function and glucose homeostasis. To the best of our knowledge, this is the first case report demonstrating the clinical advantage of the combined use of FCH PET/CT and PVS. CLINICAL TRIAL NUMBER: Not applicable
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.